Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Phil Cressman who wrote (23013)	7/9/1998 11:26:00 PM
From: Henry Niman	Read Replies (2) \| Respond to of 32384

Phil, LGND has been talking about the mouse work since Feb. I have updated the G-CSF table at home.att.net to include recent data as well as past and future abstract presentations. If you look at the tables at home.att.net or home.att.net you will see that the current status of the SBH/LGND collaboration indicates that the lead compound has been selected. I would interpret that to mean that a human version has been identified and selected and is currently in pre-clinical testing. I expect LGND to keep the structure of this compound under wraps as long as possible.